China Acknowledges Drug Safety Problems; Promises More Supervision
This article was originally published in The Pink Sheet Daily
Executive Summary
In the wake of the state execution of the former food and drug chief, State Food and Drug Agency announces stepped up enforcement and new regulations.
You may also be interested in...
Baxter Heparin Case Highlights Global Supply Chain Vulnerabilities
Correct paperwork no guarantee even legitimate API manufacturers operate according to Chinese govt. standards, chemical exec says.
Key Role For China As Sanofi’s Emerging Markets Business Grows
Continuing with a double-digit growth rate, China remained a leading driver for Sanofi’s global business in the fourth quarter. Going digital and building local partnerships emerged as key themes for Sanofi China to explore more opportunities, although it may face testing problems for its vaccine business in the country.